NeoGenomics, in concert with its subsidiary NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories that offer genetic and molecular testing services to hospitals, oncologists, pathologists, urologists and other clinicians, researchers and laboratories in the U.S. NEO performs analyses for leukemia, lymphoma and solid tumors inherent in breast, lung, colon and bladder cancers. The company also offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases.  For more information, visit the company’s website at www.neogenomics.com